The liver is an important target for gene therapy for metabolic diseases and systemic delivery of therapeutic proteins. The vast majority of our knowledge on clinical gene therapy directed to the liver comes from treatment of hemophilia A and B with adeno-associated viral (AAV) vectors. This appr…